Single mutation in peptide inhibitor of TRPV1 receptor changes its effect from hypothermic to hyperthermic level in animals


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The TRPV1 receptor plays a significant role in many biological processes, such as perception of external temperature (above 43°C), inflammation development, and thermoregulation. Activation of TRPV1 leads to the pain occurrence and decrease in the body temperature, while inhibition of this receptor can lead to an increase in the temperature. The TRPV1 peptide modulators from sea anemone Heteractis crispa extract (APHC1 and APHC3) have been previously characterized as molecules, which generated a pronounced analgesic effect and a decrease in the body temperature in experimental animals. Using the combined APHC1 and APHC3 amino acid sequences, we have prepared a hybrid peptide molecule named A13 that contains all residues potentially important for the activity of the peptide precursors. Biological tests on animals have shown that the hybrid molecule not only combines the analgesic properties of both peptides but, unlike the peptide precursors, also raises the body temperature of experimental animals.

作者简介

I. Dyachenko

Branch of the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Pushchino State Institute of Natural Science; Pushchino Scientific Center of the Russian Academy of Sciences

Email: serg@ibch.ru
俄罗斯联邦, Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290

V. Palikov

Branch of the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Pushchino State Institute of Natural Science

Email: serg@ibch.ru
俄罗斯联邦, Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290

Yu. Palikova

Branch of the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Pushchino State Institute of Natural Science

Email: serg@ibch.ru
俄罗斯联邦, Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290

G. Belous

Branch of the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Pushchino State Institute of Natural Science

Email: serg@ibch.ru
俄罗斯联邦, Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290

A. Murashev

Branch of the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Pushchino State Institute of Natural Science; Pushchino Scientific Center of the Russian Academy of Sciences

Email: serg@ibch.ru
俄罗斯联邦, Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290; Pushchino, Moscow oblast, 142290

Ya. Andreev

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Sechenov First Moscow State Medical University, Institute of Molecular Medicine; Russian University of Peoples’ Friendship

Email: serg@ibch.ru
俄罗斯联邦, Moscow, 117997; Moscow, 119991; Moscow, 117198

Yu. Logashina

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Sechenov First Moscow State Medical University, Institute of Molecular Medicine

Email: serg@ibch.ru
俄罗斯联邦, Moscow, 117997; Moscow, 119991

E. Maleeva

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: serg@ibch.ru
俄罗斯联邦, Moscow, 117997

E. Grishin

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: serg@ibch.ru
俄罗斯联邦, Moscow, 117997

S. Kozlov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

编辑信件的主要联系方式.
Email: serg@ibch.ru
俄罗斯联邦, Moscow, 117997


版权所有 © Pleiades Publishing, Ltd., 2017
##common.cookie##